Elsevier

Life Sciences

Volume 34, Issue 14, 1984, Pages 1325-1331
Life Sciences

Neuroendocrine and behavioral effects of m-chlorophenylpiperazine administration in rhesus monkeys

https://doi.org/10.1016/0024-3205(84)90003-1Get rights and content

Abstract

The effects of m-chlorophenylpiperazine (mCPP), a serotonin receptor agonist, on the release of plasma prolactin (PRL), growth hormone (GH), and cortisol in the rhesus monkey were studied. mCPP was administered intravenously at doses of 0.5, 1.5, and 3.0 mg/kg. GH and cortisol were increased significantly at all doses whike PRL was significantly increased only following administration of 3.0 mg/kg mCPP. mCPP administration also produced behavioral alterations in each monkey, including sedation, penile erection, and defecation. PRL, GH and behavioral responses to mCPP were completely blocked by pretreatment with the serotonin anatgonist metergoline (MTG). However, pretreatment with MTG failed to entirely antagonize the cortisol response to mCPP. These data suggest that mCPP has prominent neuroendocrine and behavioral effects which are mediated, in part, by serotonergic mechanisms.

References (26)

  • R.W. Fuller et al.

    Neuropharmacology

    (1981)
  • R. Invernizzi et al.

    Neurochem. Int.

    (1981)
  • P. Preziosi et al.

    Life Sci.

    (1983)
  • A. Quattrone et al.

    Eur. J. Pharmacol.

    (1981)
  • W. Puhringer et al.

    Neurosci. Lett.

    (1976)
  • R. Samanin et al.

    Psychopharm.

    (1980)
  • S. Caccia et al.

    J. Pharm. Pharmacol.

    (1981)
  • R. Samanin et al.

    Arch. Pharmacol.

    (1979)
  • R.W. Fuller et al.

    Neuroendocrinology

    (1980)
  • T. Mennini et al.

    Neurotransmitters and Their Receptors

  • A. Rokosz-Pelc et al.

    J. Pharm. Pharmacol.

    (1980)
  • S. Caccia et al.

    J. Pharm. Pharmacol.

    (1982)
  • M.G. Fong et al.

    J. Pharm. Pharmacol.

    (1982)
  • Cited by (74)

    • The neuropharmacology of prolactin secretion elicited by 3,4-methylenedioxymethamphetamine ("ecstasy"): A concurrent microdialysis and plasma analysis study

      2012, Hormones and Behavior
      Citation Excerpt :

      The pharmacological mechanisms mediating prolactin secretion have not yet been fully established. Nevertheless, it is well known that drugs that increase extracellular levels of serotonin or are direct agonists of serotonin receptors elicit prolactin secretion; whereas, conversely, drugs that increase extracellular levels of dopamine or are direct agonists of dopamine receptors suppress prolactin secretion (Aloi et al., 1984; Baumann et al., 2008). In this regard, previous data from our laboratory demonstrated that meta-chlorophenylpiperazine significantly increased both extracellular serotonin and circulating prolactin levels, whereas (+)-amphetamine significantly increased extracellular dopamine levels but significantly decreased circulating prolactin levels (Murnane et al., 2010).

    • Neural control of erection

      2004, Physiology and Behavior
      Citation Excerpt :

      Some drugs injected in conscious animals elicit erection in the absence of any sexual stimulation. This is true for m-chlorophenylpiperazine, a metabolite of trazodone and a 5-HT2C serotoninergic receptor subtype agonist, when it is injected in monkeys and rats [147,148]. In rats, systemic apomorphine [134] and the intracerebroventricular injection of oxytocin, glutamate, apomorphine, NO donors, adrenocorticotropin (ACTH), alpha-melanocyte stimulating hormone (α-MSH), Melanotan II (MT-II) and PT-141 (these four last molecules being agonists of melanocortin receptors [110,149–154]) also elicit erections.

    • Central neural regulation of penile erection

      2000, Neuroscience and Biobehavioral Reviews
    View all citing articles on Scopus
    View full text